Risankizumab Is Effective for the Management of Crohn's Disease of the Pouch

被引:0
|
作者
Shahin, Tala B. [1 ]
Khan, Nowsherwan [1 ]
Malik, Talha A. [1 ]
机构
[1] Mayo Clin Arizona, Dept Med Gastroenterol, Phoenix, AZ 85054 USA
关键词
D O I
10.1093/ibd/izae241
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:311 / 311
页数:1
相关论文
共 50 条
  • [41] Family History of Crohn's Disease Is Associated with an Increased Risk for Crohn's Disease of the Pouch
    Shen, Bo
    Remzi, Feza H.
    Hammel, Jeffrey P.
    Lashner, Bret A.
    Bevins, Charles L.
    Lavery, Ian C.
    Wehkamp, Jan
    Fazio, Victor W.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (02) : 163 - 170
  • [42] Are the New Biologics Effective in the Management of Postoperative Crohn's Disease?
    Mourad, Fadi H.
    Maalouf, Rami G.
    Aoun, Roni
    Kotze, Paulo Gustavo
    Hashash, Jana G.
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (03) : 459 - 469
  • [43] Risankizumab (Skyrizi) - An IL-23 Antagonist for Crohn's Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1666): : 205 - 207
  • [44] Risankizumab versus ustekinumab for Crohn's disease: a phase IIIb study
    Kotsiliti, Eleni
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2024, 21 (09) : 606 - 606
  • [45] Efficacy and safety of risankizumab in children with Crohn's disease: A preliminary report
    Spencer, E.
    Stein, R.
    Shalem, T.
    Zifman, E.
    Dubinsky, M.
    Tzion, R. Lev
    Turner, D.
    Assa, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1435 - I1436
  • [46] Crohn's Disease: Risankizumab as Induction- and Maintenance Therapy Comment
    Atreya, Raja
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (17) : 1086 - 1087
  • [47] Real-world effectiveness and safety of Risankizumab in Crohn's Disease
    Mcshane, C.
    Olivera Sendra, P. A.
    Kim, J.
    Milgrom, R.
    Stempak, J.
    Nguyen, G.
    Weizman, A., V
    Croitoru, K.
    Gallinger, Z.
    Huang, V
    Steinhart, H.
    Targownik, L.
    Lee, S. H.
    Silverberg, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I2023 - I2024
  • [48] Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease
    Peyrin-Biroulet, Laurent
    Chapman, J. Casey
    Colombel, Jean-Frederic
    Caprioli, Flavio
    D'Haens, Geert
    Ferrante, Marc
    Schreiber, Stefan
    Atreya, Raja
    Danese, Silvio
    Lindsay, James O.
    Bossuyt, Peter
    Siegmund, Britta
    Irving, Peter M.
    Panaccione, Remo
    Cao, Qian
    Neimark, Ezequiel
    Wallace, Kori
    Anschutz, Toni
    Kligys, Kristina
    Duan, W. Rachel
    Pivorunas, Valerie
    Huang, Xiu
    Berg, Sofie
    Shu, Lei
    Dubinsky, Marla
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (03): : 213 - 223
  • [49] Ileal pouch anal anastomosis for Crohn's disease
    Phillips, RKS
    GUT, 1998, 43 (03) : 303 - 304
  • [50] Adalimumab therapy in Crohn's disease of the ileal pouch
    Li, Yue
    Lopez, Rocio
    Queener, Elaine
    Shen, Bo
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) : 2232 - 2239